India's preferred Personal finance destination
Home Shares News Centre F&O Mutual Funds IPO Portfolio Commodity Loans Financial Planning Insurance About Us
Markets Companies Research Industries E-Mail Page
Wealth Tracker      Tax Corner NRI Centre Chat Masala Feedback

my Last 5 Scrips
Company BSE Price(Rs) % Chg
Ntpc Ltd 180.40 0.22
Icici Ba 317.05 0.64
Bharti A 496.30 0.05
State Ba 332.25 0.79
Tata Pow 93.80 0.64
Clear All Clear Last
Equity
NSE Live
Nifty Live Prices
Live Quotes
Top Gainers/Losers
Top 10 Turnover
No Delivery Stocks
BSE Live
BSE30 Live Prices
Live Quotes
Top Gainers/Losers
Top 10 Turnover
No Delivery Stocks
Market Pulse
Leaders
Laggards
FII Activity
Mutual Fund Activity
Meetings
Results Watch
Results Calendar
Results Announced
IPO Watch
Company
Snapshots
Quotes
Charts
Financials
Recent News
Broker Research
Meetings
Research Tutorial
Discussion Forum
Research
Research Reports
News Watch
Sector Watch
Economy Watch
News-Glenmark Pharmaceutical Limited
Glenmark Pharmaceutical Limited
Sector:Pharmaceuticals Pharmaceuticals - Formulations
BSE:532296NSE:GLENMARKBloomberg:GNP@INReuters:GLEN.BO
Market Lot: 1Face Value: 1ISIN Demat: INE935A01035
QuotesSnapshotChartsFinancialsResearchRecent News
Peer GroupAGM/AMMF HoldingDiscussion ForumBSE/NSE NoticesBSE/NSE Deals

 
Corporate News
22-Nov-2017       Glenmark Pharma gets nod for generic Loestrin Fe 1/20 tablets IRIS
13-Nov-2017       Glenmark Pharma aims to transform Psoriasis treatment in India IRIS
16-Oct-2017       Glenmark Pharma receives approval for generic Emend capsules IRIS
27-Sep-2017       Glenmark Pharma receives USFDA approval for Desonide lotion IRIS
20-Sep-2017       Glenmark Pharma gets USFDA nod for Nitroglycerin Sublingual tablets IRIS
19-Sep-2017       Glenmark Pharma gets USFDAs final nod for Desonide ointment IRIS
11-Sep-2017       Glenmark gets ANDA nod for generic Rythmol SR capsules IRIS
23-Aug-2017       Glenmark Pharma gets nod for Triamcinolone Acetonide ointment IRIS
02-Aug-2017       Glenmark Pharma receives USFDA nod for Acyclovir ointment USP IRIS
01-Aug-2017       Glenmark Pharma reports positive data in Phase 2a study of 'GBR 830' IRIS
25-Jul-2017       Glenmark gets final approval from USFDA for Desonide Cream IRIS
19-Jul-2017       Glenmark Pharma enters into exclusive agreement with Cyndea Pharma IRIS
07-Jul-2017       Glenmark Pharma gets USFDA nod for generic version of Azor tablets IRIS
04-Jul-2017       Glenmark Pharma gets MHRAs final nod for Maloff Protect IRIS
27-Jun-2017       Glenmark Pharma gets USFDA nod Indomethacin capsules IRIS
22-Jun-2017       Glenmark Pharma gets tentative approval for generic Vesicare tablets IRIS
21-Jun-2017       Glenmark Pharma enters into licensing pact with APC Therapeutics IRIS
14-Jun-2017       Glenmark Pharma receives USFDA nod for Saxagliptin tablets IRIS
31-May-2017       Glenmark gains on receiving final approval for generic version of Strattera Capsules IRIS
31-May-2017       Glenmark Pharma gets final nod for generic Strattera capsules IRIS

 

 


Home | Shares | F&O | Mutual Funds | Loans | Insurance | News Centre
Wealth Tracker | Tax Corner | NRI Centre | Search in myiris | Advertise
All rights reserved. IRIS Business Services Limited
Disclaimer